SCHEMBL9011022

SCHEMBL9011022

O=C(O)Cc1ccccc1N1CCN(C(=O)c2ccc3ccccc3c2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.64
TSHR P16473 3/20 0.64
ALDH1A1 P00352 6/20 0.57
HTT P42858 4/20 0.57
GAA P10253 3/20 0.57
HSD17B10 Q99714 3/20 0.57
NPC1 O15118 2/20 0.57
MAPT P10636 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
USP2 O75604 1/20 0.57
ALOX15 P16050 1/20 0.57
HPGD P15428 1/20 0.56
AKR1C1 Q04828 1/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
POLB P06746 2/20 0.55
RAB9A P51151 1/20 0.51
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9011148 0.88 LMNA (0.62) LMNATSHRALDH1A1HTTGAA
SCHEMBL9010999 0.86 LMNA (0.59) LMNATSHRALDH1A1HTTGAA
SCHEMBL9011009 0.81 LMNA (0.76) LMNATSHRALDH1A1HTTGAA
SCHEMBL7804449 0.80 LMNA (0.60) LMNATSHRALDH1A1HTTGAA
SCHEMBL4310722 0.80 TSHR (0.84) LMNATSHRALDH1A1HTTGAA
SCHEMBL27298395 0.79 TSHR (1.00) LMNATSHRALDH1A1HTTGAA
SCHEMBL9011149 0.79 NPC1 (0.58) LMNATSHRALDH1A1HTTGAA
SCHEMBL9011154 0.79 LMNA (0.73) LMNATSHRALDH1A1HTTGAA
SCHEMBL7817574 0.78 LMNA (0.58) LMNATSHRALDH1A1HTTGAA
SCHEMBL9011156 0.78 USP2 (0.66) LMNATSHRALDH1A1HTTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed